To review recent evidence regarding traditional and sex-specific factors identified among women during their reproductive years and their importance in lifetime risk for cardiovascular disease (CVD).
INTRODUCTION
Cardiovascular disease (CVD) remains the leading cause of death in the USA and worldwide for both women and men. Current trends show decreased CVD mortality rates in the USA, improvements attributed to sustained efforts to encourage smoking cessation and control CVD risk factors such as hypertension, and to improved acute care [1, 2] . An estimation of an individual's future risk for CVD is used to guide clinical recommendations for primary and secondary prevention. However, prediction models are best at assessing risk at midlife, a time when 10-year risk for a CVD event is measurable. The concept of ideal cardiovascular health across the life course, and the importance of accumulation of risk factors at younger ages, has emerged [3] . New approaches to improve early identification of high-risk individuals are being sought to enable targeting of behavioral and medical interventions at a time when they might be most effective and have the greatest impact.
An emerging epidemiologic literature has identified a number of sex-specific diagnoses presenting during the reproductive years within subgroups of women who are at high risk for CVD later in life. These include polycystic ovary syndrome (PCOS), infertility, and pregnancy complications (Table 1 ) [4] [5] [6] [7] . Typically identified by the obstetrician/ gynecologist (OB/GYN), their recognition as harbingers of CVD risk allows clinicians to identify women for whom early intervention might impact their long-term outcomes. These observations were incorporated into the 2011 updated American Heart Association (AHA) guidelines for the prevention of CVD in women, which includes for the first time the history of gestational diabetes (GDM) and gestational hypertensive disorders as risk factors for CVD [8 && ]. Because a majority of women receive reproductive healthcare from OB/GYNs during their reproductive years, these contacts with healthcare system present a key opportunity for risk identification, evaluation, and engagement in prevention of CVD [9] .
METHODS
We conducted electronic searches of the peerreviewed medical literature published during 2012 and 2013 using Medline to identify relevant studies, guidelines or policy statements. The search strategy included keywords such as women, CVD, prevention, pregnancy, hypertension, diabetes, GDM, preeclampsia, gestational hypertension, PCOS, lactation, healthcare delivery, and clinical guidelines. Articles were selected if they addressed the importance of CVD risk among reproductive-age women, sex-specific cardiovascular risk factors presenting during the reproductive years, or healthcare delivery for women. Publications prior to 2011 were identified through targeted search using PubMed when needed to provide background or context for the more recent works reviewed. They were included if they were judged to be unique and particularly relevant by both authors.
REVIEW OF RECENT PUBLICATIONS
When taken together, several streams of research, expert opinion, and policy papers published over the past year provide a rationale and vision for a new strategy toward primary and secondary prevention of CVD in women. We conceptualize the importance of this work using a life course framework, emphasizing the concept that high-risk women can be identified during their reproductive years at a time when addressing modifiable factors might be most effective and have the greatest impact.
Cardiovascular risk over the life course
Ideal cardiovascular health throughout an individual's life course places them at low lifetime risk of CVD [3] . Unfortunately, few women fall into this protected group and the rising prevalence of obesity, diabetes, and hypertension portends an increase in rates of CVD in the USA and worldwide [10] . As a group, African American women are the racial group least likely to have an ideal risk factor profile, predicting continued disparities in outcomes [10, 11] .
This year the importance of primordial and primary prevention was emphasized by the AHA in their policy statement [12 && ]. Arguing that most CVD is preventable, they recognized that the process of atherosclerosis begins during childhood and continues throughout the life course. The value of effective strategies to help women and men adopt and maintain healthy behaviors was supported by cost-effectiveness analyses. They cited, for example, a systematic review estimating $3 saved for every $1 invested in smoking cessation programs during pregnancy. In addition, they reviewed the evidence supporting the cost-effectiveness of blood pressure (BP) and lipid screening as well as screening for diabetes among high-risk populations [ Sex-specific risk factors, often identified by the obstetrician/gynecologist, provide early identification of women at high risk for CVD.
The hybrid system of healthcare for women leads to gaps in care which impact lifetime risk of CVD.
Engaging OB/GYN providers in CVD prevention may provide a new path to engaging women in primary and secondary prevention. ] using prospective cohort data for US populations. They considered the presence of an elevated BP, diabetes, elevated serum cholesterol, and tobacco use. Women whose risk factors were optimal at age 45 years were relatively protected, and had a low lifetime risk of any event related to atherosclerotic CVD (Fig. 1) . Conversely, women with CVD risk factors were significantly more likely to have a fatal or nonfatal CVD event during their lifetime [14 && ].
Traditional CVD risk among reproductive age women
Unfortunately, the rise in the prevalence of obesity among young adults is associated with an increase in hypertension and diabetes presenting during the childbearing years. Bateman et al. [15 && ] used data from the National Health and Nutrition Examination Survey (NHANES) to provide estimates of the prevalence of hypertension and other CVD risk factors among women 20-44 years of age (Table 2) . They found nearly 8% of women had hypertension, and among African American women rates were 16.6%. The prevalence increased with age and BMI; 19% of women with a BMI of 35 kg/m 2 or more had hypertension.
Huffman et al. [16] used 1988-2008 NHANES data to explore temporal trends in healthy behaviors (smoking, diet, physical activity, and obesity) and physiologic risks (measures of glucose, cholesterol, and BP) for CVD. Among women between the ages of 20 and 39 years, there was a reduction in smoking, increased healthy diet scores, and greater leisure time physical activity reported. On the contrary, there were concerning increases in BMI and fasting blood glucose [16] . These data provided little assurance that the overall risk factor profiles of women and men in the USA have improved, and reinforced the importance of a focus on screening and prevention in this age group.
Sex-specific CVD risk factors presenting during the reproductive years
Recent evidence has expanded our understanding of how common pregnancy complicationspreeclampsia, fetal growth restriction, preterm delivery, and GDM-may mark women at excess risk for CVD. In a general population, Bonamy et al. [17] have reported that, among 923 686 Swedish women with singleton first births, those delivered preterm (<37 completed weeks' gestation) or small for gestational age had excess CVD hospitalizations or deaths in the years after pregnancy. These associations were independent of socioeconomic factors, smoking, and pregnancy-related hypertension, and were detected in a population with universal access to healthcare. Similar results were found in another cohort of 750 350 women in the UK [18] . The well-established evidence linking preeclampsia to maternal CVD risk has now also been demonstrated in a study of 1 132 064 pregnancies to Asian women in Taiwan [19] . Women with early preeclampsia (delivered <32 weeks) were two times as likely to have hypertension 10 years after delivery compared with those with normotensive pregnancies, had higher BMI and waist circumferences [20] and also had excess risk of subsequent diabetes mellitus [21] . Even hypertension in pregnancy at term has been associated with excess hypertension and metabolic syndrome as soon as 2.5 years after delivery [22 & ]. Mechanisms that link reproductive events and later life CVD are not well understood; however, recent evidence suggests that elevated BP, metabolic syndrome, and perhaps inflammation may be involved [23] [24] [25] . New evidence also indicates that at least a portion of the risk associated with these factors is present prior to pregnancy, suggesting some common predisposing factors to pregnancy complications and later life CVD [26] . In addition, recent evidence indicates that lactation is associated with a healthy vascular profile in the decade after pregnancy [27 & ].
The well-established link between GDM and later CVD has now been expanded to more subtle abnormalities in glucose metabolism in pregnancy. In a prospective cohort of women with glucose tolerance testing during pregnancy, those without GDM but with impaired glucose tolerance had a more atherogenic lipid profile (higher low-density lipoprotein-c; higher total to high-density lipoprotein-cholesterol ratio; and higher apolipoprotein-B) after pregnancy compared with those with normal glucose tolerance [28] .
The recent work by Fraser et al. [29 && ] utilizing the Avon Longitudinal Study of Parents and Children cohort synthesized many of these findings by relating pregnancy complications to CVD risk factors and their impact on the Framingham 10-year risk score. Results indicated that both preeclampsia and GDM were associated with modest but significant increases in calculated CVD risk 18 years after pregnancy, compared with women without these complications.
As the Institute of Medicine revised the guidelines for gestational weight gain (GWG) in 2009, there has been heightened interest in how GWG may impact postpartum weight retention and contribute to the alarming trend of increasing adiposity among women of childbearing age [30] . A recent meta-analysis indicated that excessive GWG (compared with adequate GWG) was associated with higher weight retention after pregnancy of about 5 kg up to 15 years after pregnancy [31] . Excessive GWG is common, and has also been associated with higher BP and accumulation of central adiposity 16 years after pregnancy, marking both an important and a modifiable attribute of pregnancy related to later life CVD risk in women [30, 32] .
Outside of pregnancy, there are factors that affect women uniquely or differently than men. The best studied is PCOS, a leading cause of infertility, characterized by hyperandrogenism and high rates of metabolic syndrome. Recent work has identified subgroups with PCOS with differing levels of insulin resistance and metabolic syndrome, ranging from 38 to 80% [33] . Thus, certain PCOS phenotypes are more severely metabolically affected and may warrant early and more intensive intervention. In addition, women with at least 5 years of subfertility, who ultimately have a birth, were 20% more likely to have CVD later in life even after accounting for pregnancy complications [34] .
Missed opportunities for preventive healthcare
Women's healthcare has been called a 'patchwork quilt with gaps' [35, 36] . Today, women's preventive healthcare remains divided across the specialty fields of primary care and OB/GYN. The investigation by Lewis et al. [9] using data from the National Health Interview Survey, found 15% of women between the ages of 18 and 64 years were seen by general medical physicians, 62% by gynecologists alone, and 23% by both. Although it was clear that providers in the two fields were focused on women's health, there were differing priorities leading to differential attention to prevention guidelines. Women who saw OB/GYNs received more preventive services and counseling than those who were general medical physicians alone. However, they were unable to assess BP and lipid screening in their study.
The study published last year by Schmittdiel et al. [37 && ] was able to examine treatment for hypertension and provides important insights into the effectiveness of this hybrid system of healthcare. These investigators used clinical records to examine the healthcare received by women under 50 years of age who were enrolled in one of two health plans with 3.6 million members and had a new diagnosis of hypertension. Among this group of women, hypertension had been recognized in fewer than one-third during the course of their healthcare. A hypertension diagnosis was half as likely if a woman was being seen in an OB/GYN clinic when compared with women whose elevated BP was measured at a medicine clinic [37 && ]. Another examination of preventive health services received by women was conducted in a rural setting by Kraschnewski et al. [38] . They found women who were overweight or obese were more likely to receive counseling for healthy behaviors and CVD risk factors than women with a healthy weight. However, even among women in this high-risk group, receipt of counseling around nutrition, physical activity, weight management, as well as lipid screening during the 2-year follow-up period were each reported by fewer than 70% of the sample [38] .
What is the scope of care provided by OB/GYNs? A national survey study of OB/GYNs conducted to better understand their approach to preventive care found a majority (61%) went beyond reproductive care when providing care to women during their annual examination; however, they were unlikely to manage hypertension or elevated cholesterol [39] . A focus group study of OB/GYNs, working in academic and community settings, found most agreed that their role in prevention extended beyond reproductive care. However, there was variation in practice reported among the participants. They identified knowledge and skill deficits, concerns about liability, and barriers to prevention presented by their practice structure. Importantly, some providers emphasized difficulties in completing referrals to primary care providers [40] .
Division of healthcare between the two provider types might play a role in poor follow-up care received by women after a pregnancy complicated by GDM [41] . This year Hunsberger et al. [42] reported the results of a survey of OB/GYNs and primary care providers across the state of Oregon. When asked about their practices in follow-up care of women after GDM, OB/GYNs were more likely to recommend follow-up testing for diabetes during the postpartum period and to counsel women about their increased risk for type 2 diabetes than family medicine physicians. There was evidence suggesting that provider knowledge, attitudes and beliefs about the link between GDM and future diabetes risk influenced their testing practices. Similarly, Young et al. [43] assessed OB/GYN and primary care provider practice. They found, although nearly all primary care providers reported screening for CVD risk, fewer (70%) OB/GYNs screened routinely. There was limited knowledge across both provider groups about the link between preeclampsia and future CVD risk, and significant gaps in preventive counseling of women with a history of preeclampsia. In Germany, where there are guidelines for follow-up care after a pregnancy complicated by preeclampsia, respondents reported greater knowledge about future CVD risk [44] .
A teachable moment
It has been suggested that pregnancy and new motherhood provide a teachable moment, when motivation for behavior changes is enhanced. An important study published this year provided evidence in support of this concept. Rattan et al. [45 && ] reported the results of a longitudinal cohort study of 2992 women who had smoked tobacco daily before pregnancy and were followed for 21 years. Although there were high relapse rates immediately following delivery, they found women who had quit smoking during pregnancy had rates of smoking cessation in subsequent years which were two to four times higher than those of women who continued to smoke during their pregnancy. The authors conducted careful adjustment for individual factors potentially confounding this association, including socioeconomic, demographic, and other behavioral factors. They concluded that pregnancy provides a key opportunity to positively influence CVD risk factors [45 && ].
CONCLUSION
Research published over the past year provides new insights into the importance of addressing modifiable risk factors for CVD during women's childbearing years. It is now clear that pregnancy provides an opportunity to identify women who have a high lifetime risk for CVD. Both traditional and sex-specific risk factors are often identified by the OB/GYN provider during their course of reproductive care. Although the OB/GYN may consider CVD prevention outside of their scope of practice, they are in a key position to recognize women who are at high risk for future CVD. Engaging OB/GYN in CVD prevention will enable earlier intervention and provide a new avenue to engaging women in primary and secondary prevention.
